Progression of Metastatic Pancreatic Cancer
6 Visualizzazioni
• 07/30/23
0
0
Incorporare
administrator
Iscritti
George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti